Your browser doesn't support javascript.
loading
Lamin B1 regulates somatic mutations and progression of B-cell malignancies.
Klymenko, T; Bloehdorn, J; Bahlo, J; Robrecht, S; Akylzhanova, G; Cox, K; Estenfelder, S; Wang, J; Edelmann, J; Strefford, J C; Wojdacz, T K; Fischer, K; Hallek, M; Stilgenbauer, S; Cragg, M; Gribben, J; Braun, A.
Afiliación
  • Klymenko T; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, UK.
  • Bloehdorn J; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Bahlo J; Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital of Cologne, Cologne, Germany.
  • Robrecht S; Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital of Cologne, Cologne, Germany.
  • Akylzhanova G; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, UK.
  • Cox K; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Estenfelder S; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Wang J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, UK.
  • Edelmann J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, UK.
  • Strefford JC; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Wojdacz TK; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Fischer K; Aarhus Institute of Advanced Studies, Aarhus University, Aarhus, Denmark.
  • Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital of Cologne, Cologne, Germany.
  • Stilgenbauer S; Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital of Cologne, Cologne, Germany.
  • Cragg M; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Gribben J; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Braun A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, UK.
Leukemia ; 32(2): 364-375, 2018 02.
Article en En | MEDLINE | ID: mdl-28804121

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos B / Leucemia Linfocítica Crónica de Células B / Hipermutación Somática de Inmunoglobulina / Lamina Tipo B Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos B / Leucemia Linfocítica Crónica de Células B / Hipermutación Somática de Inmunoglobulina / Lamina Tipo B Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido